Prevalence of cerebral white matter lesions in elderly people: A population based magnetic resonance imaging study. The Rotterdam Scan Study

Journal of Neurology Neurosurgery and Psychiatry

Volumn 70, Issue 1, 2001, Pages 9-14

  De Leeuw, F E ^a,b   De Groot, J C ^a   Achten, E ^a   Oudkerk, M ^a   Ramos, L M P ^b   Heijboer, R ^a   Hofman, A ^a   Jolles, J ^c   Van Gijn, J ^b   Breteler, M M B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Magnetic resonance imaging; Population based; Prevalence; White matter lesions

Indexed keywords

ADULT; AGED; AGING; ARTICLE; BRAIN CORTEX; COGNITION; DEGENERATIVE DISEASE; DEPRESSION; DISEASE ASSOCIATION; ELDERLY CARE; FEMALE; HUMAN; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; SEX RATIO; WHITE MATTER;

AGED; AGING; BRAIN; BRAIN DISEASES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NETHERLANDS; PREVALENCE;

EID: 0035132684     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.70.1.9     Document Type: Article

References (31)

1. Breteler MMB, van Swieten JC, Bots ML, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam study. Neurology 1994;44:1246-52.
2. Longstreth W Jr, Manolio TA, Arnold A, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996;27:1274-82.
3. Liao D, Cooper L, Cai J, et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC study. Atherosclerosis risk in communities study. Stroke 1996;27:2262-70.
4. de Leeuw F-E, de Groot JC, Oudkerk M, et al. A follow up study of blood pressure and cerebral white matter lesions. Ann Neurol 1999;46:827-33.
5. Bakker SLM, De Leeuw F-E, De Groot JC, et al. Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly. Neurology 1999;52:578-83.
6. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke 1997;28:652-9.
7. Almkvist O, Wahlund LO, Andersson-Lundman G, et al. White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. Arch Neurol 1992;49: 626-32.
8. Schmidt R, Fazekas F, Kleinert G, et al. Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter. A comparative study between stroke patients and normal volunteers. Arch Neurol 1992;49:825-7.
9. Kozachuk WE, DeCarli C, Schapiro MB, et al. White matter hyperintensities in dementia of Alzheimer's type and in healthy subjects without cerebrovascular risk factors. A magnetic resonance imaging study. Arch Neurol 1990;47: 1306-10.
10. Erkinjuntti T, Ketonen L, Sulkava R, et al. Do white matter changes on MRI and CT differentiate vascular dementia from Alzheimer's disease? J Neurol Neurosurg Psychiatry 1987;50:37-42.
11. De Groot JC, De Leeuw F-E, Oudkerk M, et al. Cerebral white matter lesions and cognitive function. The Rotterdam scan study. Ann Neurol 2000;47:145-51.
12. O'Brien JT, Arnes D. White matter lesions in depression and Alzheimer's disease. Br J Psychiatry 1996;169:671.
13. Lindgren A, Roijer A, Rudling O, et al. Cerebral lesions on magnetic resonance imaging, heart disease, and vascular risk factors in subjects without stroke. A population-based study. Stroke 1994;25:929-34.
14. Ylikoski A, Erkinjuntti T, Raininko R, et al. White matter hyperintensities on MRI in the neurologically non-diseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke 1995;26:1171-7.
15. Schmidt R, Fazekas F, Offenbacher H, et al. Neuropsychologic correlates of MRI white matter hyperintensities: a study of 150 normal volunteers. Neurology 1993;43:2490-4.
16. Hofman A, Boomsma F, Schalekamp MADH, et al. Raised blood pressure and plasma noradrenaline concentrations in teenagers and young adults selected from an open population. BMJ 1979;i:1536-8.
17. Hofman A, Grobbee DE, de Jong PTVM, et al. Determinants of disease and disability in the elderly: the Rotterdam elderly study. Eur J Epidemiol 1991;7:403-22.
18. De Groot JC, De Leeuw F-E, Breteler MMB. Cognitive correlates of cerebral white matter changes. J Neural Transm Suppl 1998;53:41-69.
19. Scheltens P, Barkhof F, Valk J, et al. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. Brain 1992;115:735-48.
20. 1H Chemical shift imaging of the human brain at age 60-90 years reveals metabolic differences between women and men. Magn Reson Med 1999;42:24-31.
21. Burns A, Murphy D. Protection against Alzheimer's disease? Lancet 1996;348:420-1.
22. Goodman Y, Bruce AJ, Cheng B, et al. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons. J Neurochem 1996;66:1836-44.
23. McEwen BS, Alves SE, Bulloch K, et al. Ovarian steroids and the brain: implications for cognition and aging. Neurology 1997;48:S8-15.
24. Niki E, Nakano M. Estrogens as antioxidants. Methods Enzymol 1990;186:330-3.
25. Mooradian AD. Antioxidant properties of steroids. J Steroid Biochem Mol Biol 1993;45:509-11.
26. Mukai K, Daifuku K, Yokoyama S, et al. Stopped-flow investigation of antioxidant activity of estrogens in solution. Biochim Biophys Acta 1990;1035:348-52.
27. Behl C, Davis JB, Lesley R, et al. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 1994;77:817-27.
28. Sagara Y, Dargusch R, Klier FG, et al. Increased antioxidant enzyme activity in amyloid β protein-resistant cells. J Neurosci 1996;16:497-505.
29. Ott A, Breteler MM, van Harskamp F, et al. Incidence and risk of dementia. The Rotterdam study. Am J Epidemiol 1998;147:574-80.
30. Katzman R, Aronson M, Fuld P, et al. Development of dementing illnesses in an 80-year-old volunteer cohort. Ann Neurol 1989;25:317-24.
31. Payami H, Zareparsi S, Montee KR, et al. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet 1996;58:803-11.